265 related articles for article (PubMed ID: 25433637)
1. A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.
Su P; Li S; Chen S; Lipina TV; Wang M; Lai TK; Lee FH; Zhang H; Zhai D; Ferguson SS; Nobrega JN; Wong AH; Roder JC; Fletcher PJ; Liu F
Neuron; 2014 Dec; 84(6):1302-16. PubMed ID: 25433637
[TBL] [Abstract][Full Text] [Related]
2. The DISC1 R264Q variant increases affinity for the dopamine D2 receptor and increases GSK3 activity.
Su P; Zhang H; Wong AHC; Liu F
Mol Brain; 2020 Jun; 13(1):87. PubMed ID: 32493513
[TBL] [Abstract][Full Text] [Related]
3. Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.
Park SM; Chen M; Schmerberg CM; Dulman RS; Rodriguiz RM; Caron MG; Jin J; Wetsel WC
Neuropsychopharmacology; 2016 Feb; 41(3):704-15. PubMed ID: 26129680
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole and haloperidol protect neurite lesions via reducing excessive D2R-DISC1 complex formation.
Zheng P; Hu M; Xie Y; Yu Y; Jaaro-Peled H; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():59-69. PubMed ID: 30597182
[TBL] [Abstract][Full Text] [Related]
5. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
[TBL] [Abstract][Full Text] [Related]
8. New Concepts in Dopamine D
Urs NM; Peterson SM; Caron MG
Biol Psychiatry; 2017 Jan; 81(1):78-85. PubMed ID: 27832841
[TBL] [Abstract][Full Text] [Related]
9. The D2R-DISC1 protein complex and associated proteins are altered in schizophrenia and normalized with antipsychotic treatment.
Wang J; Su P; Yang J; Xu L; Yuan A; Li C; Zhang T; Dong F; Zhou J; Samsom J; Wong AHC; Liu F
J Psychiatry Neurosci; 2022; 47(2):E134-E147. PubMed ID: 35361701
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Lipina TV; Wang M; Liu F; Roder JC
Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
[TBL] [Abstract][Full Text] [Related]
11. Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.
Lipina TV; Kaidanovich-Beilin O; Patel S; Wang M; Clapcote SJ; Liu F; Woodgett JR; Roder JC
Synapse; 2011 Mar; 65(3):234-48. PubMed ID: 20687111
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Glycogen Synthase Kinase-3β in D
Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ
Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.
Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F
Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060
[TBL] [Abstract][Full Text] [Related]
14. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.
Lipina TV; Niwa M; Jaaro-Peled H; Fletcher PJ; Seeman P; Sawa A; Roder JC
Genes Brain Behav; 2010 Oct; 9(7):777-89. PubMed ID: 20618446
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors.
Lipina TV; Beregovoy NA; Tkachenko AA; Petrova ES; Starostina MV; Zhou Q; Li S
Front Synaptic Neurosci; 2018; 10():31. PubMed ID: 30245624
[TBL] [Abstract][Full Text] [Related]
16. Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
Urs NM; Snyder JC; Jacobsen JP; Peterson SM; Caron MG
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20732-7. PubMed ID: 23188793
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
[TBL] [Abstract][Full Text] [Related]
19. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic-Like Efficacy of Dopamine D
Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
